Audited Financial Results for the quarter and financial year ended 31st March 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.6 pts more than Nifty Microcap 250 and 14.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jaysynth Orgochem Ltd reported standalone revenue of Rs 6,592.83 lakhs for Q4 FY26 and Rs 25,537.02 lakhs for full year FY26, representing ~11% year-on-year growth from Rs 22,964.08 lakhs in FY25. However, profit after tax declined to Rs 1,474.83 lakhs in FY26 from Rs 1,588.95 lakhs in FY25, a decrease of about 7%. The company had exceptional items of Rs 330.74 lakhs in Q4 and Rs 2,059.41 lakhs on consolidated basis. EBITDA margin compressed from ~10.45% in FY25 to ~9.06% in FY26, indicating cost pressures. The Board declared a 5% dividend on equity shares. Auditors issued clean/unmodified opinions for both standalone and consolidated results.
The stock shows revenue growth but declining profitability and margin compression. Shareholders receive modest dividend. The positive operating cashflow of Rs 657.74 lakhs indicates decent cash generation despite lower PAT. Clean audit opinions are reassuring for corporate governance.